The EVLT procedure has been FDA-approved since 2002 with success rates greater than 95% and very low recurrence rates. This innovative, non-surgical procedure utilizes heat at the laser tip to seal shut (ablate) the refluxing great saphenous vein (GSV), small saphenous vein (SSV) and other superficial veins. A local anesthesia, called tumescent anesthesia, is infused around the saphenous vein to protect surrounding tissues and to numb the area.
Placement of the laser fiber is guided by ultrasound and the laser ablates the vein as it is withdrawn at a precisely calculated rate. The vein is not removed from the leg, but will close down. This treatment is performed in approximately one hour. Alternate veins have already taken over the task of returning blood to the heart, so closing this damaged vein allows for improved circulation, reduction in symptoms, and a healthier lifestyle.